Samrat Pharmachem Limited (BOM:530125)

Samrat Pharmachem Revenue

In the fiscal year ending March 31, 2026, Samrat Pharmachem had annual revenue of 2.91B INR with 1.62% growth. Samrat Pharmachem had revenue of 714.67M in the quarter ending March 31, 2026, with 0.27% growth.

• Revenue: 2.91B
• Revenue Growth: +1.62%
• P/S Ratio: 0.23
• Revenue / Employee: 103.77M
• Employees: 28
• Market Cap: 656.72M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	2.91B	46.26M	1.62%
Mar 31, 2025	2.86B	42.90M	1.52%
Mar 31, 2024	2.82B	-291.06M	-9.37%
Mar 31, 2023	3.11B	888.86M	40.06%
Mar 31, 2022	2.22B	426.92M	23.83%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 1, 2026

Data Sources Report a data error